INR102 Injection
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for INR102 Injection, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer [Phase 1, Phase 2]